EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische Studie

Open- versus closed-cell stents in transfemoral carotid artery stenting for carotid bifurcation disease: a target trial emulation

Zunwei Wang, Xiaofei Sun, Kaiyi Zhong, Yujie Sun, Yitong Ling, Yong Zhang

Journal of Vascular Surgery · 2026

DOI: 10.1016/j.jvs.2026.07.008 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Vascular Surgery, 2026. Verfasst von Zunwei Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Affiliated Hospital of Qingdao University, Qingdao, China; Qingdao Medical College, Qingdao University, Qingdao, China. Hauptthemen laut MEDLINE: Stents, Carotid Stenosis, Femoral Artery, Endovascular Procedures. Die Arbeit nennt 22 Literaturangaben. Gefördert von: Abbott Vascular.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: The comparative association of open-cell stent (OCS) and closed-cell stent (CCS) design with outcomes after protected transfemoral carotid artery stenting, particularly long-term patency, remains uncertain. This study compared OCSs and CCSs in patients with carotid bifurcation disease. METHODS: We retrospectively emulated a target trial using data from three centers. Consecutive patients who underwent transfemoral carotid artery stenting with embolic protection devices for atherosclerotic carotid bifurcation lesions were included and classified according to stent design. Stabilized inverse probability of treatment weighting was used to balance baseline covariates. Periprocedural outcomes were assessed within 30 days. Follow-up outcomes included in-stent restenosis (ISR), severe ISR, symptomatic ISR, recurrent ipsilateral ischemic events (stroke or transient ischemic attack), and target-vessel revascularization. RESULTS: Among 1024 patients, 524 (51.2%) were symptomatic and 500 (48.8%) were asymptomatic; 577 received OCSs and 447 received CCSs. Median follow-up was 26.0 months (interquartile range, 19.4-32.4 months). After inverse probability of treatment weighting, baseline covariates were well balanced. Periprocedural adverse events did not differ significantly between groups. During follow-up, CCS use was associated with higher risks of ISR (hazard ratio [HR], 1.66; 95% confidence interval [CI], 1.19-2.31; P = .003), severe ISR (HR, 1.61; 95% CI, 1.06-2.45; P = .026), symptomatic ISR (HR, 2.03; 95% CI, 1.20-3.45; P = .008), and recurrent transient ischemic attack (HR, 3.06; 95% CI, 1.24-7.55; P = .015). Any ISR and severe ISR were strongly associated with recurrent ipsilateral ischemic events (both P < .001). CCS use appeared more strongly associated with ISR in symptomatic patients, without significant interaction by symptom status (P for interaction = .206). Sensitivity analyses were concordant with the primary results. CONCLUSIONS: OCSs were associated with a lower hazard of restenosis and no material difference in periprocedural outcomes compared with CCSs. These findings support preferential consideration of OCSs at the carotid bifurcation for long-term patency, whereas CCSs may retain a theoretical advantage in unstable plaques requiring denser plaque coverage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StentsCarotid StenosisFemoral ArteryEndovascular ProceduresCatheterization, PeripheralHumansRetrospective StudiesFemaleMaleTime FactorsAgedRisk FactorsTreatment OutcomeProsthesis DesignRecurrenceVascular PatencyIschemic Attack, TransientStrokeEmbolic Protection DevicesRisk AssessmentMiddle AgedAged, 80 and over

Stichwörter der Autor:innen

Carotid artery stentingCarotid stenosisIn-stent restenosisStent cell designTarget trial emulation

Autor:innen und Institutionen

  • Department of Neurology, The Affiliated Hospital of Qingdao University, Qingdao, China; Qingdao Medical College, Qingdao University, Qingdao, China.
  • Qingdao Medical College, Qingdao University, Qingdao, China.
  • Department of Neurology, The Affiliated Hospital of Qingdao University, Qingdao, China.
  • Department of Neurology, The Affiliated Hospital of Qingdao University, Qingdao, China. Electronic address: bravezhang@126.com.

Förderung

  • Abbott Vascular

Zitieren

APA

Wang, Z., Sun, X., Zhong, K., Sun, Y., Ling, Y., & Zhang, Y. (2026). Open- versus closed-cell stents in transfemoral carotid artery stenting for carotid bifurcation disease: a target trial emulation. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2026.07.008

Vancouver

Wang Z, Sun X, Zhong K, Sun Y, Ling Y, Zhang Y. Open- versus closed-cell stents in transfemoral carotid artery stenting for carotid bifurcation disease: a target trial emulation. Journal of Vascular Surgery. 2026. doi:10.1016/j.jvs.2026.07.008

BibTeX
@article{Wang2026,
  author = {Wang, Zunwei and Sun, Xiaofei and Zhong, Kaiyi and Sun, Yujie and Ling, Yitong and Zhang, Yong},
  title = {Open- versus closed-cell stents in transfemoral carotid artery stenting for carotid bifurcation disease: a target trial emulation},
  journal = {Journal of Vascular Surgery},
  year = {2026},
  doi = {10.1016/j.jvs.2026.07.008}
}
Kostenlos starten →